MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    DIRECT DBS: A Prospective, Multicenter Clinical Study with Double-Blinding for a Directional Deep Brain Stimulation Lead – Visualization of Optimal Directionally Stimulated Anatomy

    F. Steigerwald, J. Volkmann, C. Matthies, A. Dalal Kirsch, S. Chabardes, R. de Bie, PR. Schuurman, E. Moro, V. Fraix, S. Meoni, D. Blum, L. Juarez Paz, K. Wynants, N. Van Dyck (Würzburg, Germany)

    Objective: To visualize the volumes of activated tissue in relation to the neuroanatomy for the optimal stimulation parameters in Ring Mode (omnidirectional) stimulation in comparison…
  • 2018 International Congress

    Quantitative assessment of the effectiveness of adaptive Deep Brain Stimulation in Parkinson’s disease

    D. Piña-Fuentes, M. Tijssen, M. Oterdoom, S. Little, J. van Zijl, T. van Laar, P. Brown, M. van Dijk, M. Beudel (Groningen, Netherlands)

    Objective: To determine the effectiveness of Adaptive Deep Brain Stimulation (aDBS) in PD patients compared to cDBS and non-medicated PD patients (OFF). Background: aDBS based…
  • 2018 International Congress

    The Effect of Conduction Exercise and Self-acupressure in Treatment of Parkinson’s Disease: A Pilot Study

    M. Li, K.K. Chua, C.S. Yuen, Z.Y. Zhuang, W.H. Lau, H.Y. Chow (Hong Kong)

    Objective: To evaluate the efficacy and safety of exercise regime combining Conduction exercise (CE) and self-acupressure (SA) in treating both motor symptoms (MS) and non-motor…
  • 2018 International Congress

    Design of a Phase 3 Efficacy and Safety Trial of Accordion Pill™ Carbidopa/Levodopa for Parkinson’s Disease (PD) Patients Experiencing Motor Fluctuations

    P. LeWitt, R. Gendreau, J. Meckler, N. Navon (West Bloomfield, MI, USA)

    Objective: To review the design and unique features of an ongoing phase 3 trial of a gastric-retentive formulation of carbidopa/levodopa (CD/LD), the Accordion Pill™ (AP),…
  • 2018 International Congress

    Does motor laterality affect the development of dyskinesia in patients with Parkinson’s disease?

    S. Chung, H. Yoo, J. Oh, J. Kim, P. Lee, Y. Sohn (Seoul, Republic of Korea)

    Objective: To investigate the effects of motor laterality on the development of levodopa-induced dyskinesia (LID) in patients with de novo Parkinson’s disease (PD). Background: LID…
  • 2018 International Congress

    Levodopa induced dyskinesia is preventable (15 years experience using continuous dopaminergic stimulation)

    M. Lin, R. Laureno (Washington, DC, USA)

    Objective: To evaluate whether levodopa induced dyskinesia is preventable in the treatment of patients with Parkinson’s disease. Background: Dyskinesia is one of the major complications…
  • 2018 International Congress

    Magnetic resonance imaging-guided focused ultrasound unilateral pallidotomy for Parkinson’s disease: A report of 2 patients

    H. Ito, T. Taira, S. Fukutake, K. Yamamoto, T. Yamaguchi, T. Kamei (Fujisawa, Japan)

    Objective: To present two patients of Parkinson’s disease (PD) with Magnetic resonance imaging-guided focused ultrasound (MRgFUS) unilateral pallidotomy. Background: MRgFUS is a new technology that…
  • 2018 International Congress

    Highly-selective blockade of 5-HT2A receptors with EMD-281,014 reduces the severity of L-DOPA-induced psychosis and dyskinesia in the MPTP-lesioned marmoset model of Parkinson’s disease

    A. Hamadjida, D. Bedard, S. Nuara, J. Gourdon, P. Huot (Montreal, QC, Canada)

    Objective: To investigate the effect of the highly-selective serotonin 2A (5-HT2A) receptor EMD-281,014 on L-3,4-dihydroxyphenylalanine (L-DOPA)-induced psychosis-like behaviours (PLBs) and dyskinesia in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned…
  • 2018 International Congress

    Ocular motor function in stiff person syndrome – Role of GABA and beyond

    F. Wang, L. Neilson, H. Wang, G. Wilmot, A. Shaikh (Cleveland, OH, USA)

    Objective: Delineate pathophysiology of gaze-holding function in stiff person syndrome (SPS). Background: Glutamic acid decarboxylase (GAD) catalyzes conversion of glutamate to gamma-aminobutyric acid (GABA). Anti-GAD…
  • 2018 International Congress

    Peculiarities of Opsoclonus-Myoclonus Syndrome in India: A Systematic Review of reported cases

    J. Sahu, S. Negi (Chandigarh, India)

    Objective: The aim of the study was to study the reported cases on opsoclonus-myoclonus syndrome in India and to analyze its peculiarities in comparison with…
  • « Previous Page
  • 1
  • …
  • 80
  • 81
  • 82
  • 83
  • 84
  • …
  • 177
  • Next Page »
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley